James H. McKerrow
Sandler Center at Mission Bay
University of California
San Francisco
CA 94158-2330
USA
Name/email consistency: high
- Two approaches to discovering and developing new drugs for Chagas disease. McKerrow, J.H., Doyle, P.S., Engel, J.C., Podust, L.M., Robertson, S.A., Ferreira, R., Saxton, T., Arkin, M., Kerr, I.D., Brinen, L.S., Craik, C.S. Mem. Inst. Oswaldo Cruz (2009)
- Development of protease inhibitors for protozoan infections. McKerrow, J.H., Rosenthal, P.J., Swenerton, R., Doyle, P. Curr. Opin. Infect. Dis. (2008)
- A multienzyme network functions in intestinal protein digestion by a platyhelminth parasite. Delcroix, M., Sajid, M., Caffrey, C.R., Lim, K.C., Dvorák, J., Hsieh, I., Bahgat, M., Dissous, C., McKerrow, J.H. J. Biol. Chem. (2006)
- Proteases in parasitic diseases. McKerrow, J.H., Caffrey, C., Kelly, B., Loke, P., Sajid, M. Annual. Review. Pathology (2006)
- Designing drugs for parasitic diseases of the developing world. McKerrow, J.H. PLoS Med. (2005)
- A functional proteomics screen of proteases in colorectal carcinoma. McKerrow, J.H., Bhargava, V., Hansell, E., Huling, S., Kuwahara, T., Matley, M., Coussens, L., Warren, R. Mol. Med. (2000)
- Cysteine protease inhibitors as chemotherapy for parasitic infections. McKerrow, J.H., Engel, J.C., Caffrey, C.R. Bioorg. Med. Chem. (1999)
- Development of cysteine protease inhibitors as chemotherapy for parasitic diseases: insights on safety, target validation, and mechanism of action. McKerrow, J.H. Int. J. Parasitol. (1999)
- The cysteine protease of Trypanosoma cruzi as a model for antiparasite drug design. McKerrow, J.H., McGrath, M.E., Engel, J.C. Parasitol. Today (Regul. Ed.) (1995)









